Insulin Degludec
CAS.NO: 844439-96-9
Insulin Degludec, diabetes API, is an ultra-long-acting insulin analogue. Previous studies have shown that it has an ultra-long-term hypoglycemic effect and can reduce the risk of hypoglycemia.
CAS.NO: 844439-96-9
Insulin Degludec, diabetes API, is an ultra-long-acting insulin analogue. Previous studies have shown that it has an ultra-long-term hypoglycemic effect and can reduce the risk of hypoglycemia.
| Product Name | Insulin Degludec |
| Packing Specification | 10g/100g/500g |
| Appearances | White or off-white powder |
| Activity: NLT 10Unit/mg | NLT 10Unit/mg |
| Content: 95.0%~105.0% | 95.0%~105.0% |
| Bacterial Endotoxin | Less than 10 EU/mg |
| Residual HCP | NMT 10ng/mg |
| Residual Exogenous DNA | NMT 10ng/dose |
| Macromolecular Potein | NMT 0.4% |
| HPLC Purity | ＞99.0% |
| Storage Conditions | -15℃ below, protected from light, sealed |
The data should be subject to test report of products.
Insulin Degludec easy dissolved in acidic (pH<2.5), neutral and alkaline conditions, and can be dissolved and clarified above pH7.0.
Transportation stability: It is transported in an ice pack to keep it active.
Storage stability: The product can be stored for at least 24 months at -15°C below.
Pollution should be avoided during operation.
The product should not be used for diagnosis or treatment of animals or humans.
